Investing in tomorrow's medicine
Mérieux Equity Partners is a global investment platform specialized in the healthcare & nutrition sector, working alongside entrepreneurs and companies with ambitious growth plan, offering them privileged access to sector-expertise and industrial network.
News
SERB completes acquisition of BTG Specialty Pharmaceuticals
02/03/2021
This acquisition transforms the group into a global leader and a fully integrated specialty pharmaceutical platform.
Focus on Merieux Equity Partners' upcoming fifth investment vehicle - Mérieux Participations 4
08/03/2021
The Fund will be dedicated to Growth & Buyout, with a target of € 500M.
(article in Les Echos)
AcuSurgical raises €5.75 M in Series A financing, to advance its robotic ocular microsurgery platform
18/02/2021
The company will use the proceeds of the Series A financing to conduct clinical trials and reach regulatory approval with vitreo-retinal surgery as the first indication, paving the way for future applications that are not within the reach of surgeons today.
Key figures
43
20
>700
(€ million)
2
